6.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FOLD Giù?
Forum
Previsione
Amicus Therapeutics Inc Borsa (FOLD) Ultime notizie
How Amicus Therapeutics Inc. stock reacts to Fed policy changesFree Investment Portfolio Suggestions - jammulinksnews.com
Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Amicus Therapeutics (FOLD) Expected to Announce Earnings on Thursday - MarketBeat
What drives Amicus Therapeutics Inc. stock priceExceptional profit margins - Autocar Professional
Amicus Therapeutics Inc. Stock Analysis and ForecastFree Technical Analysis Support - Autocar Professional
Edgestream Partners L.P. Takes Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
What analysts say about Amicus Therapeutics Inc. stockSkyrocketing investment returns - jammulinksnews.com
Published on: 2025-07-23 00:04:03 - jammulinksnews.com
Is Amicus Therapeutics Inc. a good long term investmentFree High-Return Strategy Alerts - jammulinksnews.com
Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025 - GlobeNewswire
Amicus Therapeutics Sets Date for Q2 Earnings: Key Updates Expected from Rare Disease Pipeline - Stock Titan
Amicus Therapeutics (NASDAQ:FOLD) Stock Rating Upgraded by Morgan Stanley - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Shares Gap UpWhat's Next? - MarketBeat
Amicus (FOLD) Gets Japan Approval for Pombiliti + Opfolda - MSN
Amicus gains as Morgan Stanley upgrades on Aurobindo case and Pom-Op switching - MSN
Amicus stock gains as Morgan Stanley upgrades (FOLD:NASDAQ) - Seeking Alpha
Amicus Therapeutics: A Biotech Buy with Legal, Product, and Market Catalysts - AInvest
Amicus Therapeutics (FOLD) Soars 10.05% on Japan Approval - AInvest
Rice Hall James & Associates LLC Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics stock upgraded to Overweight by Morgan Stanley on IP strength - Investing.com Canada
Stephens Investment Management Group LLC Makes New $5 Million Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
10 Best Small-Cap Stocks to Buy According to Billionaires - Insider Monkey
Q2 EPS Estimate for Amicus Therapeutics Increased by Analyst - MarketBeat
Zacks Research Issues Optimistic Forecast for FOLD Earnings - MarketBeat
Analysts Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) PT at $16.22 - MarketBeat
Amicus Therapeutics (FOLD): Securing Rare Disease Dominance Through Strategic Deals and Pipeline Momentum - AInvest
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):